Severe Herpes Zoster Secondary to Systemic Lupus Erythematosus Successfully Treated with Ultraviolet A1 Phototherapy: A Case Report.

Photobiomodulation, photomedicine, and laser surgery Pub Date : 2023-01-01 DOI:10.1089/photob.2022.0097

Minmin Kong, Jian Li, Huan Wang, Zhiqiang Song, Qiquan Chen

{"title":"Severe Herpes Zoster Secondary to Systemic Lupus Erythematosus Successfully Treated with Ultraviolet A1 Phototherapy: A Case Report.","authors":"Minmin Kong, Jian Li, Huan Wang, Zhiqiang Song, Qiquan Chen","doi":"10.1089/photob.2022.0097","DOIUrl":null,"url":null,"abstract":"Background: The incidence of herpes zoster (HZ) in systemic lupus erythematosus (SLE) patients is high, and the symptoms are usually severe and resistant to treatment, and the prognosis is poor. Ultraviolet (UV) A1 is a band of UV light, and UVA1 phototherapy has been widely used to treat various inflammatory skin diseases. Objective: At present, UVA1 has been considered as a potential adjuvant therapy for HZ in SLE patients. To the best of our knowledge, this is the first case report concerning the successful application of UVA1 in the treatment of HZ secondary to SLE. Methods: In this article, a clinical case report is presented, wherein the patient did not respond to conventional treatment, but was markedly responsive to the treatment of UVA1 phototherapy, and well tolerated. Results: A 29-year-old woman with severe HZ secondary to SLE was successfully treated with UVA1 phototherapy. Conclusions: UVA1 phototherapy can be used as an effective adjuvant treatment for HZ secondary to SLE.","PeriodicalId":20111,"journal":{"name":"Photobiomodulation, photomedicine, and laser surgery","volume":"41 1","pages":"26-29"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photobiomodulation, photomedicine, and laser surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/photob.2022.0097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

Background: The incidence of herpes zoster (HZ) in systemic lupus erythematosus (SLE) patients is high, and the symptoms are usually severe and resistant to treatment, and the prognosis is poor. Ultraviolet (UV) A1 is a band of UV light, and UVA1 phototherapy has been widely used to treat various inflammatory skin diseases. Objective: At present, UVA1 has been considered as a potential adjuvant therapy for HZ in SLE patients. To the best of our knowledge, this is the first case report concerning the successful application of UVA1 in the treatment of HZ secondary to SLE. Methods: In this article, a clinical case report is presented, wherein the patient did not respond to conventional treatment, but was markedly responsive to the treatment of UVA1 phototherapy, and well tolerated. Results: A 29-year-old woman with severe HZ secondary to SLE was successfully treated with UVA1 phototherapy. Conclusions: UVA1 phototherapy can be used as an effective adjuvant treatment for HZ secondary to SLE.

查看原文本刊更多论文

紫外线A1光疗成功治疗系统性红斑狼疮继发的严重带状疱疹1例。

背景:带状疱疹(HZ)在系统性红斑狼疮(SLE)患者中的发病率高，且症状通常严重且难以治疗，预后较差。紫外线(UV) A1是一束紫外线，UVA1光疗已被广泛用于治疗各种炎症性皮肤病。目的:目前，UVA1被认为是SLE患者HZ的潜在辅助治疗方法。据我们所知，这是第一个成功应用UVA1治疗SLE继发HZ的病例报告。方法:在本文中，提出了一个临床病例报告，其中患者对常规治疗没有反应，但对UVA1光疗治疗有明显反应，并且耐受性良好。结果:1例29岁女性SLE继发严重HZ患者成功接受UVA1光疗。结论:UVA1光疗可作为SLE继发HZ的有效辅助治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Photobiomodulation, photomedicine, and laser surgery

自引率

0.00%

发文量